M26.79
Other specified alveolar anomalies
Clinical Classification Guidelines
Medical Intelligence & Overview
Other specified alveolar anomalies refer to a group of rare lung conditions characterized by abnormal development or structure of the alveoli, the tiny air sacs in the lungs where gas exchange occurs. These anomalies can affect breathing efficiency and oxygen absorption, potentially leading to respiratory complications. While some alveolar anomalies are congenital (present from birth), others may develop due to various factors. Accurate identification and diagnosis are essential for managing these conditions effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lung development Prenatal environmental exposures, such as smoking or toxins Infectious diseases impacting lung tissue during fetal development Developmental disruptions during pregnancy Structural changes following certain lung diseases or injuries
Key Symptoms: Shortness of breath, especially during exertion Persistent cough Wheezing or noisy breathing Reduced exercise tolerance Recurrent respiratory infections Possible cyanosis (blue coloring of lips and fingertips) in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing other specified alveolar anomalies typically involves a combination of clinical evaluation and imaging studies. Doctors may perform the following:
Treatment Protocols: Management of alveolar anomalies depends on the severity and specific characteristics of the condition. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is M26.79 a billable ICD-10 code?
Yes, M26.79 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M26.79?
Clinical documentation must specify the nature of Other specified alveolar anomalies and any associated comorbidities for accurate reporting.
Cite this Clinical Reference